Non-small Cell Lung Cancer With Central Nervous System Metastasis
NCT06026735 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2023-09-07
Summary
Cerebrospinal fluid was obtained from the cerebrospinal cavity of non-small cell lung cancer patients with central nervous system metastasis, blood was obtained from veins, and metastatic lung cancer tumor tissue was obtained from surgically resected brain tumors or meningeal tumors. Then comprehensively analyze the exosomes contained in the aforementioned samples, and compare and analyze the clinical data of the patients, so as to explore whether the cancer cell-related substances contained in the cerebrospinal fluid, blood and tumor tissue can be used to predict lung cancer metastasis and Bioindicators of treatment effect.
Conditions
- Lung Cancer With Central Nervous System Metastasis
Interventions
- OTHER
-
lung cancer with brain /leptomeningeal metastasis
Cerebrospinal fluid was obtained from the cerebrospinal cavity of non-small cell lung cancer patients with central nervous system metastasis, blood was obtained from veins, and metastatic lung cancer tumor tissue was obtained from surgically resected brain tumors or meningeal tumors. Then comprehensively analyze the exosomes contained in the aforementioned samples, and compare and analyze the clinical data of the patients, so as to explore whether the cancer cell-related substances contained in the cerebrospinal fluid, blood and tumor tissue can be used to predict lung cancer metastasis and Bioindicators of treatment effect.
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-13
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
CTC in Lung Caner Patients With Bone Metastases
NCT04568291 ·Status: UNKNOWN ·Phase: NA
-
Genomic Study in Non-small Cell Lung Cancer Brain Metastasis
NCT04745715 ·Status: COMPLETED
-
A Prospective, Observational Trial on the Diagnostic and Prognostic of LM
NCT02607605 ·Status: UNKNOWN
-
Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis
NCT05737589 ·Status: UNKNOWN
-
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
NCT06557967 ·Status: COMPLETED
-
The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer
NCT06483919 ·Status: ACTIVE_NOT_RECRUITING
-
PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT
NCT05008796 ·Status: UNKNOWN
-
Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma
NCT05101655 ·Status: COMPLETED
-
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
NCT02505139 ·Status: COMPLETED
-
Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer
NCT07107035 ·Status: NOT_YET_RECRUITING
-
Circulating Osteocalcin-positive Cells in Breast Cancer Bone Metastasis
NCT03814811 ·Status: UNKNOWN
-
Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer
NCT03724500 ·Status: UNKNOWN
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
NCT06718972 ·Status: RECRUITING
-
Cerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer Patients
NCT06697990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis
NCT00166972 ·Status: COMPLETED
-
Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC Patients
NCT03504098 ·Status: UNKNOWN
-
ncRNAs in Exosomes of Cholangiocarcinoma
NCT03102268 ·Status: UNKNOWN
-
Therapeutic Response Evaluation by CTC Expansion System
NCT04972461 ·Status: UNKNOWN
-
Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis
NCT04516070 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
NCT00752076 ·Status: UNKNOWN ·Phase: NA
-
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
NCT05778253 ·Status: RECRUITING
-
Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients
NCT03721133 ·Status: ENROLLING_BY_INVITATION